Additionally, the suppression of the matrix metalloproteinase-2 (MMP-2) and MMP-9 expression by Luteolin is another mechanism that has been shown to be related to the anticancer effects of Luteolin on colon cancer by inhibiting angiogenesis, a crucial factor for tumor progression [43]. This evidence concerns the gene MMP2 and malignant colon neoplasm.